Nepal approves Covishield vaccine for emergency use
Jan 16 2021
Similar efforts are modeling themselves on existing vaccine documents already required by some countries for entry.
According to the details provided by the district health authorities, all health workers in the Vaccination Centre set up in Tarlai were given adequate knowledge and skills in order to ensure safe and efficient COVID-19 vaccine administration. Two vaccines in India have been approved by the government so far.
While Covishield has been developed by AstraZeneca and Oxford University, Covaxin is an indigenous vaccine developed by Bharat Biotech in collaboration with ICMR. "The priority is the whole of Brazil", he said.
Earlier on Wednesday, the department had called producers to register their vaccines for emergency use in Nepal. After the approval of the Agency, the distribution logistics should take five days.
In his letter to Modi, Bolsonaro expressed appreciation that he could count on the Prime Minister for the supply of vaccines with all possible urgency and without affecting the Indian programme. "Just as Lord Hanuman brought the holy medicine from the Himalayas to save the life of Lord Rama's brother Laksmana, and Jesus healed those who were sick..."
"We are in a unique position to be able to make so many different vaccines at a huge volume and capacity", he said.
Brazil with more than 8 million cases has the third-highest infections in the world.
Apart from Brazil and Bangladesh, which are expected to soon get supplies of the AstraZeneca shot from SII, Poonawalla said the Pune-based firm has also been approached by Morocco, South Africa and Saudi Arabia.
In its guidelines, the health ministry has advised the states and UTs not to administer the vaccine to children below 18 years of age, women, who are pregnant or not sure of their pregnancy, and lactating mothers should not receive the vaccine.
Corona vaccination will start from January 16 across the country.